Watch Ticker

Indaptus Therapeutics, Inc. Common Stock

Go to Indaptus Therapeutics, Inc. Common Stock Website

$2.27

(%)

Live

Previous Close

$2.27

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$19.4 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Indaptus Therapeutics - Indaptus Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

Company to present poster at American Society of Clinical Oncology (ASCO) Annual Meeting on June 1, 2024 highlighting initial results from its Phase 1 clinical trial of Decoy20 Company to present poster at American Society of Clinical Oncology (ASCO) Annual Meeting on June 1, 2024 highlighting initial results from its Phase 1 clinical trial of Decoy20

Related tickers: INDP.

Read Full Article

Indaptus Therapeutics - Indaptus Therapeutics Presents Positive Mechanism of Action Data at the American Association for Cancer Research Annual Meeting

Results Indicate Decoy Platform Broadly Boosts Immune System's Ability to Fight Tumors Directly and Indirectly Results Indicate Decoy Platform Broadly Boosts Immune System's Ability to Fight Tumors Directly and Indirectly

Related tickers: INDP.

Read Full Article

Trending Tickers

BTTX

XNAS

$0.01

(%)

OPRT

XNAS

$3.92

(%)

PALI

XNAS

$6.38

(%)

PRSO

XNAS

$1.39

(%)

ACRV

XNAS

$0.00

(%)